首页> 外文期刊>Pediatric radiology >Diagnostic accuracy of non-contrast magnetic resonance enterography in detecting active bowel inflammation in pediatric patients with diagnosed or suspected inflammatory bowel disease to determine necessity of gadolinium-based contrast agents
【24h】

Diagnostic accuracy of non-contrast magnetic resonance enterography in detecting active bowel inflammation in pediatric patients with diagnosed or suspected inflammatory bowel disease to determine necessity of gadolinium-based contrast agents

机译:非对比磁共振肠脑检测到诊断或疑似炎症性肠疾病患者活性肠炎的诊断准确性,以确定基于钆的造影剂的必要性

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundPediatric patients with inflammatory bowel disease (IBD) are at increased risk of gadolinium deposition given the potential need for multiple contrast-enhanced magnetic resonance enterography (MRE) exams over their lifetime.ObjectiveTo determine whether gadolinium-based contrast agents are necessary in assessing active bowel inflammation on MRE in pediatric patients with known or suspected IBD.Materials and methodsWe conducted a retrospective study of 77 patients (7-18years; 68.8% male) with known (n=58) or suspected (n=19) IBD and endoscopy with biopsy performed within 30days of MRE without and with contrast evaluated bowel and non-bowel findings. During three visual analysis sessions, two radiologists reviewed pre-, post-, and pre-/post-contrast MRE images. A third radiologist independently reviewed 27 studies to assess inter-reader reliability. We used Cohen kappa (), Fleiss kappa, ((F)), McNemar test, and sensitivity and specificity to compare MRE readings to combined endoscopic/histopathological findings (the reference standard).ResultsThe pre- and pre-/post-contrast-enhanced MRE vs. combined endoscopic/histopathological results had moderate agreement (85.7%; 0.713, P<0.001; P-value 0.549). Compared to combined endoscopy/histopathology, pre- vs. pre-/post-contrast sensitivity (67%, confidence interval [CI] 0.53-0.79 vs. 67%, CI 0.53-0.79) and specificity (80%, CI 0.59-0.92 vs. 68%, CI 0.46-0.84) varied little ( 0.42, P<0.001 and 0.32, P=0.003, respectively). The three readers had moderate agreement (85.2%; 0.695, P=0.001; P-value 0.625). More penetrating complications were identified following contrast administration (P-value 0.04).ConclusionUse of a contrast agent does not improve the detection of active inflammation in the terminal ileum and colon compared to non-contrast MRE, although use of a contrast agent does aid in the detection of penetrating disease.
机译:令人情节患者炎症性肠道疾病(IBD)鉴于潜在需要多个对比增强的磁共振肠(MRE)考试的潜在需求,促进钆沉积的风险增加。代表依赖于评估基于钆的造影剂是否需要基于钆的造影剂。儿科患者的炎症是具有已知或疑似的IBD。材料和方法对77名患者进行了回顾性研究(7-18年; 68.8%雄性),已知(n = 58)或可疑(n = 19)IBD和具有活组织检查的内窥镜检查在MRE的30天内进行,没有和对比度评估的肠道和非肠道调查结果。在三次视觉分析会议期间,两个放射科医生审查了预先和对比度/后/后/后/后的MRE图像。第三放射科医生独立审查了27项研究以评估读者互联性可靠性。我们使用了Cohen Kappa(),Fleiss Kappa,((F)),麦克马尔测试和敏感性和特异性,以比较MRE读数来组合内窥镜/组织病理学发现(参考标准).Resultsthe预先和预先形成 - 增强的MRE与结合的内窥镜/组织病理学结果具有中等协议(85.7%; 0.713,P <0.001; p值0.549)。与结合内窥镜检查/组织病理学相比,预先/后对比度敏感性(67%,置信区间[CI] 0.53-0.79与67%,CI 0.53-0.79)和特异性(80%,CI 0.59-0.92与68%,CI 0.46-0.84)变化少(0.42,P <0.001和0.32,P = 0.003)。这三名读者具有中等协议(85.2%; 0.695,P = 0.001; P值0.625)。对比度给药后鉴定出更多的渗透并发症(p值0.04)。与非对比度MRE相比,造影剂的抗腹膜和结肠中的活性炎症的检测不改善,尽管使用造影剂确实有助于检测渗透性疾病。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号